PARAMETRIC PORTFOLIO ASSOCIATES LLC - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 14 filers reported holding Astellas Pharma Inc in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q1 2021$42,052,000
+9.3%
2,723,548
+9.3%
0.02%0.0%
Q4 2020$38,487,000
+5.5%
2,492,692
+1.9%
0.02%
-7.7%
Q3 2020$36,484,000
-19.3%
2,446,946
-9.8%
0.03%
-25.7%
Q2 2020$45,182,000
+14.8%
2,712,022
+5.1%
0.04%
-2.8%
Q1 2020$39,344,000
-9.6%
2,581,630
+1.0%
0.04%
+12.5%
Q4 2019$43,518,000
+15.3%
2,555,387
-3.5%
0.03%
+6.7%
Q3 2019$37,738,000
+1.8%
2,649,222
+1.6%
0.03%
-3.2%
Q2 2019$37,067,000
-3.3%
2,606,666
+1.8%
0.03%
-6.1%
Q1 2019$38,329,000
+27.4%
2,560,399
+6.7%
0.03%
+10.0%
Q4 2018$30,093,000
-25.2%
2,399,726
+3.9%
0.03%
-14.3%
Q3 2018$40,238,000
+21.9%
2,310,549
+6.1%
0.04%
+12.9%
Q2 2018$33,014,000
+10.0%
2,177,733
+10.9%
0.03%
+3.3%
Q1 2018$30,019,000
+40.4%
1,964,567
+16.5%
0.03%
+42.9%
Q4 2017$21,382,000
+8.6%
1,686,246
+8.6%
0.02%0.0%
Q3 2017$19,696,000
+34.4%
1,553,309
+29.7%
0.02%
+16.7%
Q2 2017$14,652,000
-23.0%
1,198,005
-17.1%
0.02%
-37.9%
Q1 2017$19,030,000
+4.2%
1,444,384
+9.6%
0.03%
+16.0%
Q4 2016$18,269,000
+15.5%
1,318,081
+30.2%
0.02%
+4.2%
Q3 2016$15,815,000
+8.5%
1,012,486
+8.2%
0.02%
+4.3%
Q2 2016$14,579,000
+18.2%
935,777
+0.9%
0.02%
+15.0%
Q1 2016$12,329,000
+14.9%
927,706
+23.7%
0.02%
+11.1%
Q4 2015$10,732,000
+14.8%
749,935
+14.4%
0.02%0.0%
Q2 2015$9,345,000
-10.8%
655,299
+2.5%
0.02%
-14.3%
Q1 2015$10,473,000
+27.7%
639,566
+8.9%
0.02%
+23.5%
Q4 2014$8,200,000
-3.0%
587,396
+3.3%
0.02%
-10.5%
Q3 2014$8,450,000
+15.4%
568,883
+2.1%
0.02%
+18.8%
Q2 2014$7,324,000
+16.8%
557,394
+32.3%
0.02%
+6.7%
Q1 2014$6,272,000
+2.7%
421,221
+2.4%
0.02%0.0%
Q4 2013$6,106,000
+26.1%
411,463
+8.4%
0.02%
+15.4%
Q3 2013$4,843,000
-0.3%
379,575
+5.7%
0.01%
-7.1%
Q2 2013$4,857,000359,2140.01%
Other shareholders
Astellas Pharma Inc shareholders Q2 2017
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 469,618$7,628,0000.31%
TODD ASSET MANAGEMENT LLC 193,500$3,148,0000.07%
SCOUT INVESTMENTS, INC. 225,247$3,665,0000.05%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 193,500$3,148,0000.03%
SILVERCREST ASSET MANAGEMENT GROUP LLC 113,135$1,838,0000.01%
Private Capital Group, LLC 924$15,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 35$1,0000.00%
IFP Advisors, Inc 40$1,0000.00%
First Horizon Advisors, Inc. 120$1,0000.00%
CAPTRUST FINANCIAL ADVISORS 3,790$62,0000.00%
View complete list of Astellas Pharma Inc shareholders